Early experience with delamanid-containing regimens in the treatment of complicated multidrug-resistant tuberculosis in Hong Kong

被引：10
作者：
Chang, Kwok-Chiu [1 ]
Leung, Eric Chung-Ching [1 ]
Law, Wing-Sze [1 ]
Leung, Wai-Man [1 ]
Tai, Lai-Bun [1 ]
Lee, Shuk-Nor [1 ]
Lam, Fai-Man [2 ]
Chau, Chi-Hung [2 ]
Mok, Thomas Yun-Wing [3 ]
Yew, Wing-Wai [4 ]
Leung, Chi-Chiu [1 ]
机构：
[1] Dept Hlth, TB & Chest Serv, Hong Kong, Hong Kong, Peoples R China
[2] Grantham Hosp, TB & Chest Unit, Hong Kong, Hong Kong, Peoples R China
[3] Kowloon Hosp, Dept Resp Med, Kowloon, Hong Kong, Peoples R China
[4] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China
来源：
EUROPEAN RESPIRATORY JOURNAL | 2018年 / 51卷 / 06期
关键词：
BEDAQUILINE; PLUS;
D O I：
10.1183/13993003.00159-2018
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：4
相关论文
共 15 条
[1]   Can Intermittent Dosing Optimize Prolonged Linezolid Treatment of Difficult Multidrug-Resistant Tuberculosis? [J].
Chang, Kwok-Chiu ;
Yew, Wing-Wai ;
Cheung, Siu-Wai ;
Leung, Chi-Chiu ;
Tam, Cheuk-Ming ;
Chau, Chi-Hung ;
Wen, Peter Kin-Ho ;
Chan, Raphael Chiu-Yeung .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (07) :3445-3449
[2]   Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients [J].
Diacon, A. H. ;
Dawson, R. ;
Hanekom, M. ;
Narunsky, K. ;
Venter, A. ;
Hittel, N. ;
Geiter, L. J. ;
Wells, C. D. ;
Paccaly, A. J. ;
Donald, P. R. .
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2011, 15 (07) :949-954
[3]   Delamanid and QT prolongation in the treatment of multidrug-resistant tuberculosis [J].
Gupta, Rajesh ;
Getter, Lawrence J. ;
Hafkin, Jeffrey ;
Wells, Charles D. .
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2015, 19 (10) :1261-1262
[4]   Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use [J].
Hafkin, Jeffrey ;
Hittel, Norbert ;
Martin, Alexandra ;
Gupta, Rajesh .
EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (01)
[5]  
Kam KM, 2004, INT J TUBERC LUNG D, V8, P760
[6]   Final treatment outcomes of multidrug- and extensively drug-resistant tuberculosis patients in Latvia receiving delamanid-containing regimens [J].
Kuksa, Liga ;
Barkane, Linda ;
Hittel, Norbert ;
Gupta, Rajesh .
EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (05)
[7]   Bedaquiline plus delamanid for XDR tuberculosis [J].
Lachatre, Marie ;
Rioux, Christophe ;
Le Du, Damien ;
Frechet-Jachym, Mathilde ;
Veziris, Nicolas ;
Bouvet, Elisabeth ;
Yazdanpanah, Yazdan .
LANCET INFECTIOUS DISEASES, 2016, 16 (03) :294-294
[8]   Shorter treatment duration for selected patients with multidrug-resistant tuberculosis [J].
Leung, E. C. C. ;
Yew, W. W. ;
Leung, C. C. ;
Leung, W. M. ;
Tam, C. M. .
EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (01) :227-230
[9]   Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis [J].
Maryandyshev, Andrey ;
Pontali, Emanuele ;
Tiberi, Simon ;
Akkerman, Onno ;
Ganatra, Shashank ;
Sadutshang, Tsetan Dorji ;
Alffenaar, Jan-Willem ;
Amale, Rohit ;
Mullerpattan, Jai ;
Topgyal, Sonam ;
Udwadia, Zarir Farokh ;
Centis, Rosella ;
D'Ambrosio, Lia ;
Sotgiu, Giovanni ;
Migliori, Giovanni Battista .
EMERGING INFECTIOUS DISEASES, 2017, 23 (10) :1718-1721
[10]   Delamanid: First Global Approval [J].
Ryan, Nicola J. ;
Lo, Jin Han .
DRUGS, 2014, 74 (09) :1041-1045
12